Bayer has won an injunction in Brazil suspending a court ruling that allowed soybean farmers to claim reimbursement for royalties on expired patents for genetically modified soy seeds. The injunction maintains Bayer’s operational status quo until the appellate court reviews the case, following ongoing legal challenges concerning its Intacta RR2 PRO technology.
Bayer, a German pharmaceuticals and life sciences company, has successfully obtained an injunction that halts a recent court ruling in Brazil, which granted soybean farmers reimbursement for royalties paid on expired patents for genetically modified soy seeds. This action was confirmed by a farmers’ group and a statement from Bayer directed to stakeholders this week. The injunction specifically prevents the immediate effect of the ruling by the lower court in the Mato Grosso state, as reported by farmer lobby Aprosoja-MT.
The injunction secured by Bayer preserves the company’s existing patent rights and business model while an appeal is in process. The ongoing legal disputes reveal the complex relationship between agricultural innovation and farmers’ rights within Brazil’s prominent soybean sector. Bayer faces significant financial implications stemming from the rulings and lawsuits regarding the Intacta RR2 PRO technology.
Original Source: www.tradingview.com
